Read clinically focused news coverage of key developments from ASCRS 2026 Medscape Ophthalmology
Author: Medscape
Insurers Fail to Get Specific on Prior Authorization Reforms
An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy. Medscape Medical News
IDEAYA and Servier’s Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application
IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of eye cancer met the main goal of a mid-to-late-stage trial, sending… Reuters Health Information
Should Your Patient Be on Statins? Maybe the Eyes Can Tell
A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy. Medscape Medical News
Medscape Physician Compensation Report 2026: Positive Signs
US physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics. Medscape Medical News
Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment
Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security. Medscape Medical News
Sarcoid Uveitis: 1 in 3 Achieve Remission, Relapses Rare
Remission is achievable and relapses are uncommon in patients with sarcoid uveitis, although those with swelling in the macular region may experience delayed remission. Medscape Medical News
GLP-1 Drugs Under Scrutiny: How Real Are the Risks?
Gastrointestinal adverse effects remain a key barrier to continued use of these agents, with slower dose titration emerging as a strategy to improve tolerability and adherence. Medscape News Europe
Myopia Numbers Are Rising. Our Response Should Be Too
With myopia affecting 1 in 3 people, eye experts are urging clinicians to act now to slow progression in patients. Medscape Medical News
Female Eye Doctors Earn Less Across All Ranks
Women in academic ophthalmology earn less than men across all ranks, with a pay-gap over a full career of roughly $1 million, a study finds. Medscape Medical News
Myth of the Month: GLP-1s Have Many Dangerous Side Effects
Dr Paauw debunks concerns about thyroid cancer, suicide, and pancreatitis. Medscape Internal Medicine
Vascular Complications Tied to Poor CRC Outcomes in Diabetes
In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality. Medscape News UK
Immunovant’s Treatment for Eye Disease Fails in Late-stage Trials
Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in patients with moderate-to-severe thyroid eye disease in two late-stage… Reuters Health Information
The Death of the Medical Fax Is Foretold — Again
Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy. Medscape Medical News
Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success
Viridian Therapeutics’ experimental treatment for thyroid eye disease lagged rivals in efficacy in a late-stage… Reuters Health Information
Physicians Must Lead AI Integration in Medicine
It’s no longer a question that AI will shape the future of medicine. But it must be accountable and transparent, and physicians must lead its integration into clinical practice, writes AMA’s CEO, John Whyte, MD, MPH. Medscape Internal Medicine
Anti-VEGF Injections Safe Around CVD Events
Receiving anti VEGF eye injections around the time of a stroke or heart attack is not linked to an increased risk for death or major complications, a study finds. Medscape Medical News
Kodiak Sciences Eye Drug Succeeds in Late-stage Study
Kodiak Sciences’ experimental drug met the main goal in a late-stage trial. Reuters Health Information
Can AI Improve Glaucoma Screening in Primary Care Settings?
AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency and detection. Medscape News UK